DNTH - Dianthus Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

DNTH is currently covered by 11 analysts with an average price target of $130.14. This is a potential upside of $47.77 (57.99%) from yesterday's end of day stock price of $82.37.

Dianthus Therapeutics's activity chart (see below) currently has 59 price targets and 68 ratings on display. The stock rating distribution of DNTH is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 75.09% with an average time for these price targets to be met of 270.45 days.

Highest price target for DNTH is $200, Lowest price target is $62, average price target is $130.14.

Most recent stock forecast was given by SWAYAMPAKULA RAMAKANTH from HC WAINWRIGHT on 06-Aug-2026. First documented stock forecast 28-Sep-2023.

Best performing analysts who are covering DNTH - Dianthus Therapeutics:

Yatin Suneja Joel Beatty Alex Thompson Danielle Brill Trevor Allred Steven Seedhouse

Currently out of the existing stock ratings of DNTH, 28 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 16-May-2024

$158

$75.63 (91.82%)

$130

2 months 6 days ago
(06-Aug-2026)

8/10 (80%)

$48.08 (43.74%)

295

Buy Since 14-Oct-2025

$128

$45.63 (55.40%)

$110

2 months 6 days ago
(06-Aug-2026)

3/4 (75%)

$18.08 (16.45%)

114

Buy Since 22-Nov-2023

$122

$39.63 (48.11%)

$105

2 months 7 days ago
(05-Aug-2026)

14/15 (93.33%)

$9.5 (8.44%)

156

Buy Since 26-Dec-2023

$132

$49.63 (60.25%)

$98

4 months 2 days ago
(10-Jun-2026)

5/6 (83.33%)

$55.58 (72.73%)

187

Buy Since 14-Feb-2024

$120

$37.63 (45.68%)

$120

4 months 2 days ago
(10-Jun-2026)

4/6 (66.67%)

$43.58 (57.03%)

340

Show more analysts

Please expand the browser size to see the chart

What is DNTH (Dianthus Therapeutics) average time for price targets to be met?

On average it took 270 days for the stock forecasts to be reached, with an average price target met ratio of 75.09%.

Which analyst most recently updated their price target on DNTH (Dianthus Therapeutics)?

Swayampakula Ramakanth

Which analyst has the most public recommendations on DNTH (Dianthus Therapeutics)?

Swayampakula Ramakanth has 7 price targets and 13 ratings on DNTH

Which analyst is the currently most bullish on DNTH (Dianthus Therapeutics)?

Yatin Suneja with the highest potential upside of $117.63

Which analyst is the currently most reserved on DNTH (Dianthus Therapeutics)?

Trevor Allred with the lowest potential downside of -$33.35
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?